There have been three different cases involving pts receiving medication infusions at an impaired / incorrect rate with the use of the baxter brand filter.This possible device error has potentially affected pts' clinical course in the hosp.The third case also involved epoprostenol.This pt was admitted for shortness of breath and she was, similar to the second case, continued on her home dose and regimen.Despite this, the pt desaturated requiring rapid response and transfer to the icu.The pt experienced add'l episodes that required rapid response and add'l transfers in and out of the icu.The pulmonary hypertension rn examined the pt and examined the pt and noticed that the infusion was not flowing forward at the pt's insertion site; therefore the epoprostenol concentration was lower.It was only then that the pt's status stabilized and she was able to be transferred out of the icu.Of note, this pt was also admitted 6 months prior to this event with the same chief complaint.She was continued on her home regimen of the epoprostenol at that time and no issues were reported.The only difference between the two hospitalizations is that the institutions started using the baxter filters for infusions.The three cases involved different medications, pumps, and staff, but all three of these cases used the baxter filter, so there's a concern that the filter is causing infusion flow problems.Ref mw5090870, mw5090871.
|